Literature DB >> 8661412

Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain.

D E Breiding1, M J Grossel, E J Androphy.   

Abstract

The bovine papillomavirus type 1 E2 transactivator has a large amino-terminal 215-residue transcriptional activation domain (TAD) that is active in Saccharomyces cerevisiae and higher eukaryotic cells. Comparison to other transcriptional activators suggests that its functions may be mediated in part through two acidic regions, A1 and A2, in this domain. We have characterized the functional elements within the E2 TAD using LexA-E2 fusions and by screening randomly generated libraries of E2 mutations for transcriptional activation in yeast. The A1 region was highly sensitive to substitutions that reduce negative charge, although there was not a perfect correlation between overall charge and transcriptional activity. Mutations were isolated within a hydrophobic amino acid motif that overlaps the A2 region and resembles elements described in other viral and cellular transactivation domains. When fused to the LexA DNA binding domain, this hydrophobic motif within the acidic A2 region was unable to activate transcription in S. cerevisiae. Multiple highly defective mutations primarily altering hydrophobic amino acids were identified in the distal third of the E2 TAD. The transcription phenotype of many of these E2 TAD mutations was similar in yeast and COS cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661412     DOI: 10.1006/viro.1996.0350

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins.

Authors:  J D Benson; R Lawande; P M Howley
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Papillomavirus E2 protein is regulated by specific fibroblast growth factor receptors.

Authors:  Marsha DeSmet; Sriramana Kanginakudru; Leny Jose; Fang Xie; Timra Gilson; Elliot J Androphy
Journal:  Virology       Date:  2018-06-06       Impact factor: 3.616

3.  Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.

Authors:  E C Goodwin; L K Naeger; D E Breiding; E J Androphy; D DiMaio
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain.

Authors:  D E Breiding; F Sverdrup; M J Grossel; N Moscufo; W Boonchai; E J Androphy
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB.

Authors:  J M Yao; D E Breiding; E J Androphy
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Minute virus of mice NS1 interacts with the SMN protein, and they colocalize in novel nuclear bodies induced by parvovirus infection.

Authors:  Philip J Young; Klaus T Jensen; Lisa R Burger; David J Pintel; Christian L Lorson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32.

Authors:  J D Fontes; B Jiang; B M Peterlin
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

8.  The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.

Authors:  Michael K Baxter; Maria G McPhillips; Keiko Ozato; Alison A McBride
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1.

Authors:  David Gagnon; Hélène Sénéchal; Claudia M D'Abramo; Jennifer Alvarez; Alison A McBride; Jacques Archambault
Journal:  Virology       Date:  2013-03-11       Impact factor: 3.616

10.  Acetylation of conserved lysines in bovine papillomavirus E2 by p300.

Authors:  Edward J Quinlan; Sara P Culleton; Shwu-Yuan Wu; Cheng-Ming Chiang; Elliot J Androphy
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.